NDRA
NDRA
NASDAQ · Health Care

Endra Life Sciences Inc

$3.89
+0.10 (+2.64%)
As of Feb 8, 2:32 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +731.4% upside
Low Target $22.21
Average Target $32.34
High Target $49.71
Current Price $3.89
Current
$3.89
Target
$32.34
$22.21 $32.34 avg $49.71
Scenario Analysis
Bear Case
$22.21
471.0%
Low target
Base Case
$32.34
+731.4%
Avg target
Bull Case
$49.71
+1,177.9%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$36.12
-89.2% from high
52-Week Low
$24.97
+-84.4% from low
Target vs 52W High
$32.34
-10.5% vs high
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Buy 34 68% $293.85 +6.2%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +11.4%
ISRG
Intuitive Surgical Inc
Buy 42 69% $219.77 -55.0%
SYK
Stryker Corp
Strong Buy 36 75% $338.36 -5.6%
MDT
Medtronic Plc
Buy 35 57% $192.46 +87.0%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -67.6%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -76.3%
BSX
Boston Scientific Corp
Strong Buy 40 93% $136.36 +78.8%